Azenta — Fiscal 2026 Earnings Summary

Azenta reported fourth-quarter fiscal 2026 revenue of $167 million, representing a 5% year-over-year increase, while full-year revenue reached $622 million, also up 5%. The company posted a net loss from continuing operations of $157.9 million for the full year, primarily driven by a $149 million non-cash goodwill impairment charge, though adjusted diluted EPS for the period was $0.48. Looking ahead to fiscal 2027, Azenta forecasts total revenue between $648 million and $660 million, with adjusted EBITDA margins expected to expand by 200 to 250 basis points. Recent strategic moves include the acquisition of SynPlexity and a technology agreement with Elegen to enhance gene synthesis capabilities.